July 09, 2025

PXF: A Silent Threat to Vision

A study in the clinical recognition and management of pseudoexfoliation syndrome

The Ophthalmologist

July 08, 2025

Photobiomodulation for Dry AMD

PBM represents an exciting advancement in eye care for the millions of people in the United States with dry AMD. As with any new technology, some work is needed prior to introducing it in your practice.

Ophthalmic Professional

July 08, 2025

Training Staff for the Presbyopia Journey

Presbyopia isn’t new—but the way we treat it has changed dramatically. As we continue to embrace these advancements, let’s also commit to the one constant that always makes a difference: a well-trained, well-informed team.

Ophthalmic Professional

July 08, 2025

Are You Ready for a Medicare Optical Inspection?

Laurie Brown reviews the key requirements that some optical locations may have overlooked, helping you ensure full compliance.

Ophthalmic Professional

July 08, 2025

Melanomas: Clinical Decision Making with AI

Artificial intelligence support for opticians assessing small pigmented choroidal lesions

The Ophthalmologist

July 01, 2025

Getting YAG in the Bag: Tips for Success

Joe Munsell, OD, dedicated part of his 2025 Optometry’s Meeting lecture, “Optometric Laser Procedures: Pearls, Pitfalls, and How to Successfully Incorporate Into Your Practice,” to clinical pearls related to the procedure.

Optometric Management

July 01, 2025

Dr. Shannon Boye

Atsena Therapeutics’ founder and chief scientific officer discusses her role as CSO, the latest developments with ATSN-101, trends in the ocular gene therapy space, and more.

Ophthalmology Management

July 01, 2025

Bring Clinical Research Into Your ASC

Performing clinical trials allows the ASC to position itself as a leading center for new and innovative techniques and devices. It also allows the staff to take pride in what they offer patients and to feel that they are contributing to the field of science. Here's how to implement them successfully.

Ophthalmology Management

July 01, 2025

Director of Clinical Resources Group Announces Report on Ocular Risks of Glucagon-Like Peptide-1 Agonists

During the AOA’s 2025 House of Delegates meeting, director of the AOA’s clinical resources group, Andrew Morgenstern, OD, announced the report, “Glucagon-like Peptide-1 Receptor Agonists and Ocular Health: Guidance for Optometric Practice.”

Optometric Management